cyt-0851
Cyt 0851 is a drug used to treat Breast Cancer, CLL, DLBCL, and other conditions. Cyt 0851 is being actively studied in 1 study; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Cyteir Therapeutics, Inc. | Dana Farber Cancer Institute | |
| Florida Cancer Specialists and Research Institute | ||
| John Theurer Cancer Center at HUMC |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Recruiting
- Malignancy
- +14 more
- CYT-0851
- +3 more
- Scottsdale, Arizona
- +17 more
2022-03-07
Mar 7, 2022